Tumor volume estimation and quasi-continuous administration for most effective bevacizumab therapy J Sápi, L Kovács, DA Drexler, P Kocsis, D Gajári, Z Sápi PloS one 10 (11), e0142190, 2015 | 161 | 2015 |
Modeling of tumor growth incorporating the effects of necrosis and the effect of bevacizumab DA Drexler, J Sápi, L Kovács Complexity 2017 (1), 5985031, 2017 | 62 | 2017 |
Model-based angiogenic inhibition of tumor growth using modern robust control method L Kovács, A Szeles, J Sápi, DA Drexler, I Rudas, I Harmati, Z Sápi Computer Methods and Programs in Biomedicine 114 (3), e98-e110, 2014 | 61 | 2014 |
Model-based analysis and synthesis of tumor growth under angiogenic inhibition: a case study DA Drexler, L Kovács, J Sápi, I Harmati, Z Benyó IFAC Proceedings Volumes 44 (1), 3753-3758, 2011 | 59 | 2011 |
Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2) YC Changchien, P Tátrai, G Papp, J Sápi, L Fónyad, M Szendrői, Z Pápai, ... Journal of translational medicine 10, 1-9, 2012 | 50 | 2012 |
Potential benefits of discrete-time controllerbased treatments over protocol-based cancer therapies J Sápi, DA Drexler, L Kovács Acta Polytechnica Hungarica 14 (1), 11-23, 2017 | 38 | 2017 |
A minimal model of tumor growth with angiogenic inhibition using bevacizumab DA Drexler, J Sápi, L Kovács 2017 IEEE 15th International Symposium on Applied Machine Intelligence and …, 2017 | 37 | 2017 |
Model-based optimal control method for cancer treatment using model predictive control and robust fixed point method B Czako, J Sápi, L Kovács 2017 IEEE 21st International Conference on Intelligent Engineering Systems …, 2017 | 31 | 2017 |
Qualitative analysis of tumor growth model under antiangiogenic therapy–choosing the effective operating point and design parameters for controller design J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács Optimal Control Applications and Methods 37 (5), 848-866, 2016 | 29 | 2016 |
Nodular fasciitis: a comprehensive, time-correlated investigation of 17 cases Z Sápi, Z Lippai, G Papp, L Hegyi, J Sápi, K Dezső, K Szuhai Modern Pathology 34 (12), 2192-2199, 2021 | 28 | 2021 |
Flat control of tumor growth with angiogenic inhibition DA Drexler, J Sápi, A Szeles, I Harmati, A Kovács, L Kovács 2012 7th IEEE International Symposium on Applied Computational Intelligence …, 2012 | 26 | 2012 |
Linear state-feedback control synthesis of tumor growth control in antiangiogenic therapy J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács 2012 IEEE 10th International Symposium on Applied Machine Intelligence and …, 2012 | 26 | 2012 |
Positive nonlinear control of tumor growth using angiogenic inhibition DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 50 (1), 15068-15073, 2017 | 25 | 2017 |
Imaging method for model-based control of tumor diseases B Kiss, J Sápi, L Kovács 2013 IEEE 11th International Symposium on Intelligent Systems and …, 2013 | 20 | 2013 |
H∞ control of nonlinear systems with positive input with application to antiangiogenic therapy DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 51 (25), 146-151, 2018 | 19 | 2018 |
Optimal discrete time control of antiangiogenic tumor therapy DA Drexler, J Sápi, L Kovács IFAC-PapersOnLine 50 (1), 13504-13509, 2017 | 19 | 2017 |
Positive control of a minimal model of tumor growth with bevacizumab treatment DA Drexler, J Sápi, L Kovács 2017 12th IEEE Conference on Industrial Electronics and Applications (ICIEA …, 2017 | 18 | 2017 |
Model-based angiogenic inhibition of tumor growth using feedback linearization A Szeles, DA Drexler, J Sápi, I Harmati, L Kovács 52nd IEEE Conference on Decision and Control, 2054-2059, 2013 | 17 | 2013 |
Comparison of mathematical tumor growth models J Sápi, DA Drexler, L Kovács 2015 IEEE 13th International Symposium on Intelligent Systems and …, 2015 | 16 | 2015 |
Model-based angiogenic inhibition of tumor growth using modern robust control method A Szeles, J Sápi, DA Drexler, I Harmati, Z Sápi, L Kovács IFAC Proceedings Volumes 45 (18), 113-118, 2012 | 16 | 2012 |